Publication | Closed Access

Antiviral activity of 2′,3′-dideoxy-β-L-5-fluorocytidine (β-L-FddC) and 2′,3′-dideoxy-β-L-cytidine (β-L-ddC) against hepatitis B virus and human immunodeficiency virus type 1 in vitro

Antiviral ActivityMedicineImmunologyAntiviral ResponseHepatitisVirologyAntiviral Drug DevelopmentAntiviral TherapyAntiviral DrugHivHepatitis B VirusPharmacologyAntiviral Compound